At NPS Pharma, the most important thing they make is a difference in the lives of patients with rare diseases. People living with rare diseases have incredible courage. They have to, because they have few, if any, treatment options and are often overlooked because of the rarity of their disorders. Globally, there are approximately 7,000 rare disease and treatments exist for less than 500 of them. They can do better than this. They must do better than this. Their sole focus at NPS Pharma is rare diseases, and they are building a global pipeline of first-in- or best-in-disease therapies. Patients are at the center of everything they do. Each of us brings a personal passion to fulfilling their mission: To pioneer and deliver innovative therapies that transform the lives of patients with rare diseases worldwide. Their values and culture are the most important drivers of their success and will support us in achieving their vision of creating a world where every person living with a rare disease has a therapy. Integrity, respect, excellence, personal ownership, teamwork, entrepreneurial spirit and fun are the values that guide their work each day and what they expect from each other. They are the fabric of the NPS Pharma culture. They develop therapies for patients with significant unmet medical needs. In 2013, they launched their first product in the U.S. called Gattex® (teduglutide [rDNA origin]) for injection, which was also approved in Europe where they are launching it this year in select countries under the trade name Revestive®. NPS Pharma is currently conducting a global registration study for teduglutide in pediatric patients, because children have considerable, unique needs. NPS Pharma is also developing rhPTH [1-84], an investigational medicine being studied for the treatment for Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone. Hypoparathyroidism is the only classic endocrine disorder without a parathyroid hormone replacement therapy. Their Biologics License Application is currently under FDA review and they are planning to file a European Marketing Authorization Application for rhPTH[1-84] this year. Their lead pipeline candidate is NPSP795, a small molecule being developed for the treatment of Autosomal Dominant Hypocalcemia or ADH. There is no approved therapy for this ultra-rare, life-long genetic disorder that affects both adults and children. They have a Phase 2a proof-of-concept study underway to evaluate NPSP795 for the treatment of adults with ADH. Today, NPS Pharma is a global rare disease company with approximately 300 employees and operations in the U.S., Canada, Europe, Latin America and Japan. They are passionate about transforming the lives of patients with rare diseases through science. Every day, they connect with people living with rare diseases. Every day, they connect with physicians, researchers, universities, policy makers and companies throughout the globe working in rare diseases. Together they can make a difference.

Korea Hydro & Nuclear Power Co. Ltd. produces and supplies electric power. It operates nuclear plants in Busan, Ulsan, North-Gyeongsang, and North-Jeonla and renewable energy generation facilities. The company was founded on April 2, 2001 and is headquartered in Seoul, South Korea.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Guangzhou Kunyuan Fangqing Medical Technology Co., Ltd., established on 2018-03-30, Business scope includes software technology promotion services;Information Technology Consulting Services;Data Processing and Storage Services;computer technology development,Technical Services;Technical development and technical service of digital medical imaging software;Technology development and technical services of artificial intelligence algorithm software;Technical development and technical services of medical imaging data transmission equipment;Medical technology research and development;Data processing and storage product design;Medical technology promotion service;computer manufacturing;Integrated Cabinet Manufacturing;Operation of non-licensed medical devices;computer retail;computer wholesale;software wholesale;software retail;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);software development;software service;Computer Peripheral Manufacturing;General Machinery Sales;Medical Research and Experimental Development;the medical,Manufacturing of surgical and veterinary instruments;medical diagnosis,Monitoring and treatment equipment manufacturing;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;medical diagnosis,Monitoring and treatment equipment retail;Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail);Medical Data Acquisition,storage

Guangzhou Boshi Medical Technology Co., Ltd., established on 2017-05-11, Business scope includes research on network technology,to develop;computer technology development,Technical Services;Technical development and technical services of medical imaging data transmission equipment;Technology development and technical services of artificial intelligence algorithm software;Technical development and technical service of digital medical imaging software;Medical equipment rental service;nursing service(does not involve accommodation,medical diagnosis,Treatment and Rehabilitation Services);Biomedical Technology Research;Medical technology research and development;Medical technology promotion service;Medical Technology Consulting,communication service;Counseling Services(Does not include medical counseling,Medical Psychological Training,Medical psychological counseling and other medical behaviors);Commodity wholesale trade(Except for licensed and approved products);Operation of non-licensed medical devices;Medical supplies and equipment retail(Does not contain drugs and medical devices);software wholesale;software retail;software development;software service;Software Testing Services;Software technology promotion service;Data Processing and Storage Services;Data transaction service;Data processing and storage product design;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Business Consulting Services;Business Management Consulting Services;Marketing Planning Service;Corporate Image Planning Service;Import and export(Excluding franchised products);Technology Import and Export;Undertaker of large-scale summits in the medical professional field;Medical technology transfer service;Health Management Consulting Services(Medical treatment activities subject to approval,Except for psychological counseling,Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);E-commerce information consultation;Conference and Exhibition Services;Electronic product testing;Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail)

Beijing Jishuitan Hospital (JST Hospital; simplified Chinese: 北京积水潭医院; traditional Chinese: 北京積水潭醫院), is a large-scaled first-level hospital in Beijing, focusing mainly on orthopaedics and burn surgery. Founded in 1956, the hospital now has around 1000 beds. Its performance in medical care, teaching and researching led to it becoming the Fourth Medical College of Peking University. The hospital now has 200 doctors and 2200 other staff. The hospital has fully equipped departments of orthopaedics, spine surgery, adult joint reconstructive surgery, orthopaedic trauma, hand surgery, paediatric orthopaedics, bone tumor, sports medicines and burn surgery.

Hunan Xiangchu Mingyitang Medical Technology Co., Ltd., established on 2013-06-08, The scope of business includes a class of medical devices,Class II medical device,medicine,Chinese medicine,Health products,Diabetes Intervention Technology,cosmetic,Research and Development of Special Dietary Foods;Engineering and Technology Research and Experimental Development;medical information,Technical Advisory Services;Internet of Things Technology Services;Organization of business activities;Internet information service;Application software development;Class I medical device,Class II medical device,cosmetic,Sales of health products;Daily necessities,Sanitation products,Wholesale of Chinese Herbal Pieces;Management of health care industry projects,operate;Planning creative services;Conference Services;Health and Wellness Consulting(Does not contain medical diagnoses);Nutrition and Health Consulting Services;Chinese medicine promotion;Brand Promotion Marketing;Traditional Chinese Medicine Culture Promotion;Planning of business activities;Medical laboratory technical service;Traditional Chinese medicine service;Traditional Chinese Medicine Cultural Services;Marketing Planning Service;Information system integration service;Medical device technology promotion service;Hospital Operations and Management;Chain enterprise management;Organization of training events;Biotechnology Extension Services;Educational Consulting;education management;Traditional Chinese Medicine Hospital;Internet hospital;Community Medical and Health Center;Chinese medicine clinic;Chinese clinic;Traditional Chinese Medicine Health Care Services(non-medical);Organize medical personnel to carry out diagnosis and treatment services in legal medical institutions;Application and Promotion of Diabetes Intervention Technology;Acquisition of Chinese herbal medicines,wholesale;Acquisition of agricultural and sideline products;Chinese herbal medicine processing(limited branch);Production of special dietary food(limited branch);Cardiovascular Specialist;Diabetes Specialist;health management;Biological resources,Stem cell and immune cell storage and biotransformation medical technology services;tablet,hard capsule,Granules,syrup,oral solution(Contains Chinese herbal extracts)production and sales(limited branch).(Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Taifeng Biotechnology Co., Ltd., established on 2012-03-15, Business scope includes licensed projects:pharmaceutical production;Drug retail;food production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of daily chemical products;Sales of daily chemical products;food sales(Only sell prepackaged food)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)